Supplementary Material – Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context

Figshare Future Science Group; Antonio Gonzalez-Martın; Ursula A Matulonis; Jacob Korach; Mansoor R Mirza; Kathleen N Moore; Xiaohua Wu; Whitney York; Divya Gupta; Stanislav Lechpammer; Bradley J Monk

doi:10.25402/fon.20237181

Conference proceeding

Supplementary Material – Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context

Figshare Future Science Group, Antonio Gonzalez-Martın, Ursula A Matulonis, Jacob Korach, Mansoor R Mirza, Kathleen N Moore, Xiaohua Wu, Whitney York, Divya Gupta, Stanislav Lechpammer, …

01/01/2022

DOI: https://doi.org/10.25402/fon.20237181

Abstract

Cancer therapy (excl. chemotherapy and radiation therapy)

Plain Language Summary of Publication

Metrics

1 Record Views

Details

Title: Supplementary Material – Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context
Creators: Figshare Future Science Group
Antonio Gonzalez-Martın
Ursula A Matulonis
Jacob Korach
Mansoor R Mirza
Kathleen N Moore
Xiaohua Wu
Whitney York
Divya Gupta
Stanislav Lechpammer
Bradley J Monk
Publisher: Future Science Group
Identifiers: 991006057767402656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Conference proceeding

Supplementary Material – Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context

Abstract

Related links

Metrics

Details